Menopause Hormone Therapy (HRT) in Boston, MA

Bioidentical hormones in Boston: what it means

"Bioidentical" describes a hormone whose chemical structure matches one the body makes. Estradiol, the main estrogen the ovaries make before menopause, and micronized progesterone both fit that description. Neither has to be compounded: FDA-approved estradiol comes as pills, patches, gels, sprays, vaginal creams and rings, and progesterone as capsules.

Compounded hormones are a different thing: a pharmacy prepares them for one patient, as a cream, a capsule or a pellet. Compounded drugs are not FDA-approved, so the FDA cannot assure their safety, effectiveness or dose. The FDA says it has no evidence that compounded "bioidentical hormones" are safe and effective, or more effective than FDA-approved hormone therapy. The National Academies, reviewing them for the FDA in 2020, called their wide use a public health concern.

Through VevaMD, a physician licensed in Massachusetts decides whether hormone therapy fits you and, if so, the form: an estradiol pill, patch, cream or vaginal cream, with progesterone if you have a uterus. Pellets are not part of it. Since the pharmacy that fills these prescriptions also compounds, ask whether yours is an FDA-approved product or compounded. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

The NPI registry counts 472 OB-GYNs practicing in Boston, about 71.1 for every 100,000 residents against 17.8 nationally and above Massachusetts's 21.9, a higher rate than 93% of the cities VevaMD covers. With about 71,396 women aged 45 to 64 living in Boston, that is about 150 for each OB-GYN in the city, before counting any younger patients.

Counting the area around it, 719 OB-GYNs practice in Boston or within 10 miles and 1,030 within 25 miles: 28.8 for every 100,000 of the 3,577,884 people who live within 25 miles, a dense supply. None of this replaces your own OB-GYN or a menopause doctor you trust; VevaMD adds an online route, with a physician licensed in Massachusetts reviewing your answers from home in Boston.

Then there are pellets, implanted under the skin at a clinic; compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG advises FDA-approved hormone therapy over compounded preparations.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11